Wang, Siwei
Li, Ming
Zhang, Jingyuan
Xing, Peng
Wu, Min
Meng, Fancheng
Jiang, Feng
Wang, Jie
Bao, Hua
Huang, Jianfeng
Ren, Binhui
Yu, Mingfeng
Qiu, Ninglei
Li, Houhuai
Yuan, Fangliang
Zhang, Zhi
Jia, Hui
Lu, Xinxin
Zhang, Shuai
Wang, Xiaojun
Xu, Youtao
Xia, Wenjia
Liu, Tongyan
Xu, Weizhang
Xu, Xinyu
Sun, Mengting
Wu, Xue
Shao, Yang
Wang, Qianghu
Dai, Juncheng
Qiu, Mantang
Wang, Jinke
Zhang, Qin
Xu, Lin
Shen, Hongbing
Yin, Rong
Funding for this research was provided by:
Key Project of Cutting-edge Clinical Technology of Jiangsu Province (BE2016797)
National Science Foundation of China (82073235, 81872378, 81672295, 81572261, 81501977)
Project of Jiangsu Provincial Medical Talent (ZDRCA2016033)
Article History
Received: 2 August 2022
Accepted: 16 September 2022
First Online: 1 October 2022
Declarations
:
: Study conforms to the Declaration of Helsinki. Written informed consent was collected from each patient upon sample collection according to the protocols approved by the Institutional Review Board of Jiangsu Cancer Hospital (JSLMTCR-2017-002).
: Not applicable.
: MW, HB, XW, and YS are employees of Nanjing Geneseeq Technology, Inc. All remaining authors have declared no conflict of interests.